Pharmacologically controlled neurotrophic factor gene therapy for Parkinson's disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Göttingen, Georg-August Universität, Dissertation, 2019
- Schlagwort
-
Parkinson's disease
Gene therapy
- Ereignis
-
Veröffentlichung
- (wo)
-
Göttingen
- (wer)
-
Niedersächsische Staats- und Universitätsbibliothek Göttingen
- (wann)
-
2019
- Urheber
- Beteiligte Personen und Organisationen
-
Kügler, Sebastian
Kügler, Sebastian
Zweckstetter, Markus
- Handle
-
21.11130/00-1735-0000-0003-C174-0
- URN
-
urn:nbn:de:gbv:7-21.11130/00-1735-0000-0003-C174-0-7
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:54 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cheng, Shi
- Kügler, Sebastian
- Zweckstetter, Markus
- Niedersächsische Staats- und Universitätsbibliothek Göttingen
Entstanden
- 2019
Ähnliche Objekte (12)
Parenteral drug therapy in spasticity and Parkinson's disease
Magnetic Resonance Imaging Biomarkers for Clinical Symptoms and Therapy in Parkinson’s disease
Comparative analysis of the effects of neurotrophic factors CDNF and GDNF in a nonhuman primate model of parkinson’s disease
Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of parkinson’s disease-lessons from transgenic mice
LSVT-BIG therapy in Parkinson's disease: physiological evidence for proprioceptive recalibration
npj Parkinson's Disease
Parkinson’s disease revisited: multiple circuitopathies
Muscle Synergies in Parkinson’s Disease
Apomorphine in Parkinson's disease
Apomorphine in Parkinson's disease
Apomorphine in Parkinson's disease
Landscape of pain in Parkinson’s disease : impact of gender and Parkinson’s disease clinical phenotype
Parenteral drug therapy in spasticity and Parkinson's disease
Magnetic Resonance Imaging Biomarkers for Clinical Symptoms and Therapy in Parkinson’s disease
Comparative analysis of the effects of neurotrophic factors CDNF and GDNF in a nonhuman primate model of parkinson’s disease
Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of parkinson’s disease-lessons from transgenic mice
LSVT-BIG therapy in Parkinson's disease: physiological evidence for proprioceptive recalibration
npj Parkinson's Disease
Parkinson’s disease revisited: multiple circuitopathies
Muscle Synergies in Parkinson’s Disease
Apomorphine in Parkinson's disease
Apomorphine in Parkinson's disease
Apomorphine in Parkinson's disease
Landscape of pain in Parkinson’s disease : impact of gender and Parkinson’s disease clinical phenotype
Parenteral drug therapy in spasticity and Parkinson's disease
Magnetic Resonance Imaging Biomarkers for Clinical Symptoms and Therapy in Parkinson’s disease
Comparative analysis of the effects of neurotrophic factors CDNF and GDNF in a nonhuman primate model of parkinson’s disease
Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of parkinson’s disease-lessons from transgenic mice
LSVT-BIG therapy in Parkinson's disease: physiological evidence for proprioceptive recalibration
npj Parkinson's Disease
Parkinson’s disease revisited: multiple circuitopathies
Muscle Synergies in Parkinson’s Disease
Apomorphine in Parkinson's disease
Apomorphine in Parkinson's disease
Apomorphine in Parkinson's disease